Photos & Field work
May 2023 | Field trip to Kisumu, Kenya
Prof. Tim Anderson, Dr. Frédéric Chevalier, and Dr. Winka Le Clec'h visited their collaborator, Dr. Eric Ndombi, and his team at KEMRI for a ten-day workshop. They taught the Kenyan team how to prepare DNA libraries from pools of miracidia for next-generation sequencing and learned how to catch snails in the field for microbiome sampling.
September 2024 | Field trip in Kenya to collect Schistosome parasites and their snail hosts
Dr. Jenna Hulke spent three weeks in Kenya, from September 9th to 30th, collecting Bulinus sp. snails and schistosome parasites: Schistosoma haematobium, which infects humans, and S. bovis, which infects cattle.
Over the course of three weeks, with the help of our Kenyan collaborators at KEMRI and Prof. Sam Loker from the University of New Mexico, Jenna collected snails, screened them for pre-existing infections, collected schistosome parasites from infected patients and cattle, and exposed uninfected snails to these parasites. She then returned to Texas Biomed with both exposed and some uninfected snails to establish S. haematobium and S. bovis parasite populations in the Anderson Lab. The goal is for Jenna to cross these two parasite species and evaluate the impact of hybridization on the fitness and genome of the hybrid offspring.
2024 | Field trip in Côte d’Ivoire and Guinea to collect Schistosome miracidia from infected patients
Dr. Yves-Nathan Tian-Bi, from the University Félix Houphouët-Boigny in Abidjan (Côte d’Ivoire), spent several weeks in Côte d’Ivoire and Guinea collecting pools of Schistosoma mansoni and Schistosoma haematobium miracidia from infected patients. These miracidia pools will be shipped to Texas Biomed in San Antonio for gDNA extraction and the preparation of targeted capture libraries. The objective is to investigate the genetic diversity of several key parasite genes involved in drug response, including:
- TRPMPZQ: Linked to praziquantel (PZQ) response
- SOX13: Potentially associated with the expression of TRPMPZQ
- SULT-OR: Linked to oxamniquine resistance
This project, funded by the Bill & Melinda Gates Foundation, aims to conduct molecular surveillance of Schistosomiasis endemic areas and screen for potential mutations in these critical Schistosoma genes. Identifying mutations that confer resistance or reduced sensitivity to anti-schistosome drugs will provide valuable insights for improving schistosomiasis treatment strategies.